Home Site Map Contact Us Social Media MSF Offices xml  

Sleeping Sickness Threatens 60 Million

January 23, 2009

This fatal disease threatens some 60 million people. In 2006, there were 17,000 reported cases. But a new treatment is now available. It’s the result of three studies conducted by Epicentre, an epidemiological center created by MSF, and the DNDi, a foundation that develops medicines for neglected tropical diseases. Started nine years ago, these studies now show the efficacy of a combination of eflornithine with nifurtimox.

This fatal disease threatens some 60 million people. In 2006, there were 17,000 reported cases. But a new treatment is now available. It’s the result of three studies conducted by Epicentre, an epidemiological center created by MSF, and the DNDi, a foundation that develops medicines for neglected tropical diseases. Started nine years ago, these studies now show the efficacy of a combination of eflornithine with nifurtimox.

 

Tags: Sleeping Sickness, Access to Medicines, Neglected Diseases

Donate Now How your funds are used

86 cents of every dollar supports our programs.

ABOUT OUR WORK

Learn more about how we work or view stories from the field.

 

MSF midwife, Rebecca Ullman, talks about the difficult decisions she had to make in Ivory Coast.

Doctors Without Borders
in your inbox:

Enter your email address for updates on our work.


Subscribe to
Doctors Without Borders